Syndromic infections

When a feverish, severely ill child arrives at a hospital in sub-Saharan Africa, doctors often cannot tell whether malaria, a bacterial infection, or something else is the cause—and that uncertainty kills. This matters because the same symptoms—fever, low haemoglobin—can stem from multiple diseases, yet each requires a different treatment. Without a clear diagnosis, children may receive the wrong drugs or no effective treatment at all. The problem is compounded for newborns and infants, whose antibiotic doses are based on historical practice rather than solid evidence, leading to wide variation in what they actually receive. If this research succeeds, it will produce evidence-based treatment guidelines for common syndromic infections in low-resource settings. That means hospitals could follow standard protocols proven to reduce deaths, rather than relying on guesswork. The work also aims to slow antimicrobial resistance by ensuring antibiotics are used only when necessary and at the correct doses—a benefit that extends beyond individual patients to the global drug supply. For the youngest infants, better dosing schedules could directly improve survival rates in the first month of life.